Fitchburg, WI, United States of America

Said A Goueli

USPTO Granted Patents = 24 

 

Average Co-Inventor Count = 2.8

ph-index = 9

Forward Citations = 202(Granted Patents)


Location History:

  • Madison, WI (US) (2003 - 2010)
  • Ficthburg, WI (US) (2018)
  • Fitchburg, WI (US) (2000 - 2022)

Company Filing History:


Years Active: 2000-2025

Loading Chart...
Loading Chart...
24 patents (USPTO):Explore Patents

Sure, here is the article about inventor Said A Goueli:

Title: Spotlight on Inventor Said A Goueli from Fitchburg, WI

Introduction: Inventor Said A Goueli, based in Fitchburg, WI, is a prolific innovator with an impressive portfolio of 22 patents to his name. His groundbreaking work has spanned various fields, leaving a lasting impact on the world of science and technology.

Latest Patents: Among his latest patents is "Activation of bioluminescence by structural complementation," a revolutionary method that involves assembling a bioluminescent complex from non-luminescent peptide and/or polypeptide units. Additionally, Goueli has introduced "Systems and methods for determining cyclic nucleotide concentration and related pathway activation," offering advanced tools for detecting cyclic nucleotide concentrations in samples.

Career Highlights: Said A Goueli is associated with Promega Corporation, a prominent player in the biotechnology industry. His contributions have significantly enhanced the company's innovative capabilities, pushing the boundaries of scientific research and discovery.

Collaborations: Throughout his career, Goueli has collaborated with esteemed colleagues such as Hicham Zegzouti and Andrew S Dixon. Together, they have worked on various projects that have led to groundbreaking inventions and advancements in the field of biotechnology.

Conclusion: In conclusion, Said A Goueli stands out as a pioneering inventor whose relentless pursuit of innovation has led to the development of cutting-edge technologies. His creative solutions and collaborative spirit continue to inspire the scientific community, shaping the future of biotechnology and beyond.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…